HJ
Therapeutic Areas
Bonesupport Holding AB Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CERAMENT® G (Gentamicin) | Chronic osteomyelitis (bone infection) | Approved/Commercial |
| CERAMENT® V (Vancomycin) | Chronic osteomyelitis (bone infection), particularly gentamicin-resistant cases | Approved/Commercial |
| CERAMENT® | Bone void filling in benign bone tumors (e.g., simple bone cysts) | Approved/Commercial |
Leadership Team at Bonesupport Holding AB
RC
Ruben Carrillo
Chief Executive Officer (CEO)
LH
Lars Høgsted
Chief Financial Officer (CFO)
DJ
Dr. James P. Wenz
Chief Medical Officer (CMO)
RD
Richard Davis
President, U.S. Commercial Operations
AL
Anna Ljung
General Counsel & Head of Quality and Regulatory Affairs